Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Substance Use Disorders > Opioid Use Disorder Treatments > Flashcards

Opioid Use Disorder Treatments Flashcards

1
Q

Psychosocial treatments for OUD may include…

A

Psychotherapy
CBT
Structured counselling + motivational interviewing
Case+ + contingency management, care coordination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Addictions and substance use disorders are often associated with…

A

Trauma and psychiatric disorders

Substance is often used as a coping mechanism for trauma + psych conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

For any substance use disorder, we should start with…

A

The person - underlying conditions, rather than the medications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Withdrawal management is simply…

A

Helping the individual to deal with withdrawal symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Withdrawal management alone is ____, because..

A

Not effective and is associated with risks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Withdrawal management alone may be a potential option for someone with…

A

Mild OUD, and is undergoing proper psychosocial supports (and does not want to undergo long-term agonist treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Withdrawal mangement/detox alone is associated with…

A

Increased HIV and HCV transmission
Increased relapse rates
Increased morbidity and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Naltrexone affects opioid receptors by…

A

Being a full opioid receptor antagonist that blocks euphoric effects of opioids

Oral formulation of naloxone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Oral naltrexone could be considered as…

A

An adjunct treatment upon cessation of opioid use

This is a weak recommendation with low quality evidence; if patient is deficient of endogenous opioid, this would not be helpful to treat that deficit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benefits of using naltrexone for OUD include…

A

Ease of administration
No induced tolerance during prolonged treatment
No potential for dependence/misuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Risks with using naltrexone involve…

A

A higher risk of overdose for patients who stop treatment, and relapse to opioid use due to decrease in tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

A meta-analysis found that oral naltrexone found ____ compared to placebo.

A

No significant difference in retention or abstinence rates

ER-naltrexone monthly did show increased retention in tx, increased abstinence rates, and decreased opioid cravings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The most desired treatment for OUD is…

A

Opioid agonist therapy (OAT)

Give patient safe levels of opioid to try and help reduce cravings/withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The dose of suboxone is based on…

A

The buprenorphine component

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

1st line treatment for OUD is…

A

Buprenorphine/naloxone (Suboxone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

2nd line for OUD treatment is…

A

Methadone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

3rd line for OUD treatment is…

A

Slow-release oral morphine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The purpose of naloxone in the suboxone formulation is to…

A

Prevent diversion of suboxone - cannot be crushed/snorted for effect, has no effect unless injected and may negate opiate effect if injected

Oral/sublingual naloxone is NOT absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Buprenorphine is available in different formulations, such as…

A

Patches - indicated for pain, not OUD
Buccal films or sublingual tablets, + naloxone (suboxone)
XR injection (Sublocade), OUD monthly injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Buprenorphine has ____ affinity for Mu opioid receptors, which affects other opiates by…

A

High affinity (strong binding ability). Will displace heroin/other opiates from their receptors and block their effects, also protecting from overdose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Buprenorphine is a ____ at the Mu opioid receptors and an ____ at the Kappa and Delta opioid receptors

A

Partial agonist at Mu opioid-receptor
Antagonist at Kappa + Delta opioid receptors

Antagonism at kappa + delta may benefit mood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Buprenorphine has a slow dissociation from the opioid receptor which means…

A

Duration of action increases with increases in dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Partial agonism of buprenorphine means…

A

Opiate has a ceiling effect - no further opioid effect above a certain dose.
Also safer in overdose

Overdose still possible if patient is opioid naive

24
Q

Common AE’s with bup/nal include…

A

Headache, pain, withdrawal syndrome
Nausea, constipation, abdominal pain,
Insomnia
Runny nose, sweating

Similar to other opioids, usually better tolerated

Withdrawal symptoms are involved due to partial agonism (especially when switching from a full agonist opioid

25
Q

Some rarer AE’s that may occur with bup/nal include…

A

Flu-like symptoms, muscle aches
Tooth disorder, dyspepsia

Psych - Depression, anxiety, nervousness, somnolence, dizziness, paresthesia

26
Q

Notable DI’s with bup/nal include…

A

Usage of opioids for analgesia: diminished effect and may require reassessment in acute pain

Alcohol, BZD’s - increased risk of respiratory depression (less than full opioid agonists)

Diminished analgesia due to Mu-receptor occupation

27
Q

Advantages of bup/nal over methadone include…

A

Lower risk of overdose, better safety profile
Less AE’s
Lower risk of diversion
Less DI’s
Milder withdrawal sx’s when discontinued

Methadone is a CYP drug
Slow dissociation means milder withdrawal symptoms

28
Q

Suboxone efficacy compared to methadone is…

A

No significant difference in terms of treatment retention at medium/high doses of suboxone.
No difference between the two in decreasing illicit opioid use

29
Q

Notable counselling points regarding suboxone administration include…

A

Dissolve under tongue, which may take up to 10 minutes. Avoid eating + drinking during this time

No therapeutic effect if swallowed

30
Q

Precipitated withdrawal is anticipated when switching a patient from full opioid agonist to bup/nal because…

A

Buprenorphine displaces full opiate agonists from their receptors and partially activates receptor compared to full agonists - overall net decrease in receptor activation will cause withdrawal symptoms

31
Q

Precipitated withdrawal can occur ____ after the 1st dose of bup/nal.

A

30-60 minutes

32
Q

Ways to minimize risk of precipitated withdrawal include…

A

Delaying 1st dose until moderate withdrawal is experienced
Start with low dose, communicate risk, and monitor patient
Micro-dosing induction

33
Q

COWS is…

A

Clinical Opiate Withdrawal Scale

34
Q

When waiting for a patient to experience moderate withdrawal to induce bup/nal, their COWS score should be…

A

Greater than 12

Adjuvant agents could be given to help patient with withdrawal sx’s

Does require patient to be moderately uncomfortable and may decrease buy-in to treatment

35
Q

In general, the duration of time between last opioid dose and onset of moderate withdrawal (COWS greater than 12) is usually…

A

Short-acting: 12-16 hours
Intermediate-acting: 17-24 hours
Long-acting: 30-36 hours or more

36
Q

Microdosing bup/nal is a strategy to avoid precipitated withdrawal by…

A

Accumulation of buprenorphine at receptor due to long t1/2 - very small doses should not precipitate withdrawal.
Overtime, an increasing amount of full agonist will be replaced by buprenoprhine at receptor

Full opioid dose they have been using is usually continued

37
Q

Most regimens involved with microdosing suggest increasing the dosage of bup/nal daily for ____ days, and stopping full agonist on…

A

7 days. Stopping full agonist on the 8th day

38
Q

Methadone MOA is…

A

Full opioid agonist

39
Q

Methadone should be tried for individuals who…

A

Respond poorly to bup/nal, or when bup/nal is not the preferred option

40
Q

Compared to suboxone, methadone has potentially better retention rates in people with…

A

Moderate-severe OUD
Long history of OUD
Heroin addiction

May also be considered for those who are severely unstable and would be at great risk for harm if lost to follow up

41
Q

Onset of methadone is…

A

0.5-1 hour

42
Q

Duration of action for methadone is…

A

For analesia ~4-8 hours
OAT 22-48 hours with repeated dosing

43
Q

Half life of methadone is ____, which is significant because…

A

24-36 hours (range of 8-59), drug can accumulate and cause opioid toxicity if doses are increased too fast

44
Q

AE’s of methadone include…

Typical opioid AE’s - full agonist

A

CNS depression (somnolence, mild cognitive dysfunction), agitation
Nausea, constipation
Hormonal dysfunction
Weight gain, tooth decay
QT prolongation

45
Q

Notable DI’s with methadone involve…

A

Anything with CYP3A4 and 2D6
Additive QT prolongation and CNS depressive agents
Anything that increases risk of serotonin syndrome

46
Q

____ doses of methadone are more effective, but dosing should be based on…

A

Higher doses - should be based on clinical judgement due to differences in metabolism, co-morbidities, and DI’s

Example of co-morbidities = liver disease, QT prolongation

47
Q

Methadone doses should not be adjusted sooner than ____ due to…

A

Every 5 days, due to long half-life (risk of accumulation

48
Q

Methadone dose titrations need to be restarted after missing ____ days, due to…

A

3 days: due to loss of tolerance, avoid opioid toxicity

49
Q

Methadone formulations are available as…

AKA methadose

A

10 mg/mL oral concentrates

One is red, cherry-flavoured and the other is dye-free, sugar-free, unflavoured

50
Q

Slow-release oral morphine (SROM) can be considered for patients…

A

When 1st and 2nd line treatment options are ineffective or CI

51
Q

Efficacy of SROM compared to methadone…

A

Is similar; no difference in tx retention but higher AE’s

Less overall evidence available for SROM

52
Q

The only SROM that has been studied is the ____ release product, and should be adjusted no sooner than…

A

24 hour release product; adjusted no sooner than q48 hours

Due to elimination half-life of 11-13 hours

53
Q

To reduce risk of diversion of SROM, it should first be prescribed as…

A

Once-daily witnessed doses

54
Q

Individuals with severe OUD who inject opioids may not adequately benefit from oral OAT for a variety of reasons, such as…

A

Having cravings despite optimal OAT dosing
Inability to reach therapeutic dose
Insufficient improvements in health, social fx, or QoL
Opting not to initiate oral OAT

55
Q

Meta-analyses found that in individuals that are tx refractory to methadone, Rx injectable diacetylmorphine is beneficial in reducing…

Canada = IV hydromorphone

A

Illicit opioid use
Premature tx discontinuation
Criminal activity
Incarceration
Mortality

Improvement in overall health + social functioning

Substance Use Disorders (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions